2017
DOI: 10.3892/or.2017.5861
|View full text |Cite
|
Sign up to set email alerts
|

Pseudolaric acid B inhibits neuroglioma cell proliferation through DNA damage response

Abstract: Human neuroglioma is one of the most common malignant intracranial tumors in neurosurgery, and accounts for more than 50% of all brain cancer cases. Thus, a clinically effective drug with which to treat neuroglioma is urgently required. Pseudolaric acid B (PAB), a diterpene acid isolated from the root and trunk bark of Pseudolarix kaempferi Gordon (Pinaceae), was found to inhibit cell growth in a variety of cancer cell lines, but to date the effect of PAB on neuroglioma remains unclear. MTT analysis confirmed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Hence, in this study, we investigated the location of γ-H2AX in the nucleus after infection with EVA71. We selected pseudolaric acid B (a diterpene acid) as a positive control because it induces the DDR [ 36 ]; subsequently, we extracted nuclear and cytoplasmic proteins for Western blotting analysis. The results showed that levels of γ-H2AX protein were increased in the nucleus at 36 h after treatment with 4 µM pseudolaric acid in RD cells ( Figure 3a ).…”
Section: Resultsmentioning
confidence: 99%
“…Hence, in this study, we investigated the location of γ-H2AX in the nucleus after infection with EVA71. We selected pseudolaric acid B (a diterpene acid) as a positive control because it induces the DDR [ 36 ]; subsequently, we extracted nuclear and cytoplasmic proteins for Western blotting analysis. The results showed that levels of γ-H2AX protein were increased in the nucleus at 36 h after treatment with 4 µM pseudolaric acid in RD cells ( Figure 3a ).…”
Section: Resultsmentioning
confidence: 99%
“…PAB has been reported to target tubulin ( 20 , 21 ). Therefore, the current study investigated the effects of PAB on the microtubule networks of RD cells by tubulin immunofluorescence staining.…”
Section: Resultsmentioning
confidence: 99%
“…Then, it was investigated that G2/M phase‐related drugs inhibited EVD68 production, it was found that pseudolaric acid B (Song et al, ; Wang et al, ), oridonin (Zheng et al, ), and erianin (Wang et al, ) did not affect intracellar viral protein expression although they had the trend to decrease the expression, therefore, it was speculated that the decreased trend was due to decreased viral mRNA level by pseudolaric acid B, oridonin, and erianin, respectively. Meanwhile, only oridonin affected supernatant viral protein expression, but all of them decreased supernatant viral genome level, and the fold difference in the TCID50/ml and the supernatant viral genome level between the control‐treated and pseudolaric acid B‐treated cells was 2.34 × 10 2 and 11.31, oridonin was 5.10 × 10 3 and 54.05, and erianin was 1.23 × 10 3 and 108.70, therefore, pseudolaric acid, oridonin, and erianin inhibiting viral genome packaged into virions partly explained the decreased production.…”
Section: Discussionmentioning
confidence: 99%
“…Then, it was investigated that G2/M phase-related drugs inhibited EVD68 production, it was found that pseudolaric acid B (Song et al, 2017;Wang et al, 2018), oridonin (Zheng et al, 2017), and erianin (Wang et al, 2016) did not affect intracellar viral protein expression although they had the trend to decrease the expression, therefore, it was speculated that the decreased trend was due to decreased viral mRNA level by pseudolaric acid B, oridonin, and erianin, respectively.…”
Section: Discussionmentioning
confidence: 99%